Furthermore, positive metabolic syndrome criteria were demonstrated in 60% of participants affected by CKD without WT history, suggesting the combination of WT1 abnormalities and metabolic issues are likely the main contributing factors to the CKD development in these patients. Here, WT1 is linked to chronic kidney disease.